maintenance dose
Showing 1 - 25 of >10,000
Wheat Hypersensitivity, Immunotherapy Trial in Bangkoknoi (Wheat (Four times per week))
Recruiting
- Wheat Hypersensitivity
- Immunotherapy
- Wheat (Four times per week)
-
Bangkoknoi, Bangkok, ThailandSiriraj Hospital
Sep 12, 2023
Premature Birth, NEUROPROTECTION, MAGNESIUM SULPHATE Trial in Zagazig (Magnesium sulfate loading with maintenance dose,
Not yet recruiting
- Premature Birth
- +4 more
- Magnesium sulfate loading with maintenance dose
- Magnesium sulfate loading dose only
-
Zagazig, Sharkia, EgyptFaculty of medicine, Zagazig University
Dec 31, 2022
Hypertension Trial in Tucson (Inspiratory muscle strength training)
Not yet recruiting
- Hypertension
- Inspiratory muscle strength training
-
Tucson, ArizonaArizona Respiratory and Neurophysiology Laboratory
Feb 24, 2023
TSI and Its Relationship With Graves' Disease Relapse
Completed
- Graves Disease
- +2 more
- TSI
-
Ho Chi Minh City, VietnamHoa Hao Clinic
Feb 2, 2023
Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)
Not yet recruiting
- Ovarian Cancer
- +3 more
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jul 18, 2023
Maintenance Dose, Osteocalcin, Vitamin K Deficiency Trial in Skjetten (Jarlsberg Cheese)
Completed
- Maintenance Dose
- +2 more
- Jarlsberg Cheese
-
Skjetten, Akershus, NorwaySkjetten Legesenter
Jun 27, 2022
T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)
Recruiting
- T Lymphoblastic Leukemia/Lymphoma
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023
Diabetes Type 2 - Insulin-Treated Trial in Pittsburgh (Smartphone application and web portal, Standard Insulin Therapy
Active, not recruiting
- Diabetes Mellitus Type 2 - Insulin-Treated
- Smartphone application and web portal
- Standard Insulin Therapy Education
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Jan 6, 2023
Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)
Not yet recruiting
- Uncontrolled Asthma
- Experimental: CHF6001 3200 μg
- Placebo Comparator: CHF6001 Placebo
- (no location specified)
Sep 7, 2023
Multiple Myeloma Trial in Hangzhou (Ixazomib plus low-dose lenalidomide, Ixazomib)
Recruiting
- Multiple Myeloma
- Ixazomib plus low-dose lenalidomide
- Ixazomib
-
Hangzhou, Zhejiang, ChinaYang Xu
Feb 9, 2023
Germ Cell Tumor, Non-seminomatous Germ Cell Tumor, Ovarian Germ Cell Tumor Trial in Indianapolis (Etoposide)
Recruiting
- Germ Cell Tumor
- +2 more
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Dec 20, 2022
Diabetes, Type 2, Coronary Artery Disease Trial in Jacksonville (Ticagrelor, Clopidogrel)
Completed
- Diabetes Mellitus, Type 2
- Coronary Artery Disease
-
Jacksonville, FloridaUniversity of Florida
Nov 2, 2021
Ticagrelor Trial (Ticagrelor 60mg)
Not yet recruiting
- Ticagrelor
- Ticagrelor 60mg
- (no location specified)
Apr 25, 2023
Metastatic Non-squamous Lung Cancer Trial in Villejuif (Pembrolizumab 200 mg Q6W, Pemetrexed 500 mg/m^2 Q3W, Pembrolizumab 200
Not yet recruiting
- Metastatic Non-squamous Lung Cancer
- Pembrolizumab 200 mg Q6W
- +2 more
-
Villejuif, Val-de-Marne, FranceInstitut Gustave Roussy
Jan 11, 2023
Non Small Cell Lung Cancer Trial (Navtemadlin, Navtemadlin Placebo, Pembrolizumab)
Not yet recruiting
- Non Small Cell Lung Cancer
- Navtemadlin
- +2 more
- (no location specified)
Jan 27, 2023
Renal Anemia Trial in Hanzhou (Recombinant human erythropoietin injection, Human erythropoietin injection)
Recruiting
- Renal Anemia
- Recombinant human erythropoietin injection
- Human erythropoietin injection
-
Hanzhou, Zhejiang, ChinaThe First Affiliated Hospitial,College of Medicine,Zhejiang Univ
Nov 17, 2022
Psychiatric Disorders, Insomnia Trial in Copenhagen NV (Melatonin, Quetiapine, Placebo)
Recruiting
- Psychiatric Disorders
- Insomnia
- Melatonin
- +2 more
-
Copenhagen NV, DenmarkMental Health Center Copenhagen
Sep 25, 2023
Sarcoma, Ewing, Sarcoma Trial in Santa Monica (Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus
Active, not recruiting
- Sarcoma, Ewing
- Sarcoma
- Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS)
-
Santa Monica, CaliforniaSarcoma Oncology Research Center
Jan 19, 2023
Multiple Myeloma Trial in Stockholm (CellProtect, Isatuximab)
Recruiting
- Multiple Myeloma
-
Stockholm, SwedenKarolinska University Hospital, Huddinge
Aug 16, 2022
Chronic Insomnia, Cancer-related Problem/Condition, Cancer-Related Syndrome Trial in Philadelphia (Cognitive Behavioral Therapy
Not yet recruiting
- Chronic Insomnia
- +2 more
- Cognitive Behavioral Therapy for Insomnia
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 31, 2022
Primary CNS Lymphoma Trial in Paris (Rituximab, Methotrexate, Temozolomide)
Active, not recruiting
- Primary Central Nervous System Lymphoma
- Rituximab, Methotrexate, Temozolomide
-
Paris, FranceGroupe Hospitalier Pitie Salpetriere
Feb 10, 2022
CNS Lymphoma Trial in Seongnam-si (lenalidomide)
Recruiting
- Central Nervous System Lymphoma
-
Seongnam-si, Please Select, Korea, Republic ofSeoul National University Bundang Hospital
Feb 18, 2022
Hepatitis B Vaccine Trial (60 µg dose hepatitis B vaccine, 20 µg dose hepatitis B vaccine)
Completed
- Hepatitis B Vaccine
- 60 µg dose hepatitis B vaccine
- 20 µg dose hepatitis B vaccine
- (no location specified)
Nov 26, 2021
MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)
Active, not recruiting
- Myelodysplastic Syndromes (MDS)
- Acute Myelogenous Leukemia (AML)
- low dose 5'-azacitidine
-
Basking Ridge, New Jersey
- +6 more
Dec 1, 2022